Knudsen LB, Wichmann Madsen L, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Jacobsen SD, Moses AC, Mlck A-M, Nielsen HS, Nowak J, Solberg H, Thi TDL, Zdravkovic M (2010) Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
For drawing precise doses from the mixed vial, a 1mL insulin syringe with fine gradations is ideal
Compounded GLP-1 therapies are not FDA-approved
So, none of these studies suggest a cause-and-effect relationship between semaglutide medications and hair loss
The American Diabetes Association guidelines do not specifically address continuing or discontinuing GLP-1 receptor agonists or dual agonists like tirzepatide when antibiotics are prescribed